Beyond antibiotics: 3d-transition metal ions − serum albumin −indocyanine green complex as a novel multifunctional NIR-responsive therapeutic platform for treating diabetic foot ulcer
{"title":"Beyond antibiotics: 3d-transition metal ions − serum albumin −indocyanine green complex as a novel multifunctional NIR-responsive therapeutic platform for treating diabetic foot ulcer","authors":"Jayashree Roy, Indranil Banerjee","doi":"10.1016/j.mehy.2025.111628","DOIUrl":null,"url":null,"abstract":"<div><div>Diabetic Foot Ulcer (DFU) is a severe chronic diabetes mellitus complication with delayed wound healing. A number of factors such as antibiotic-resistant bacterial infection, ischemia, matrix metalloproteinases (MMPs)- mediated degradation of granulating tissue, fibroblast senescence and hypoalbuminemia contribute to the severity of DFU. Present therapies are often found to be inactive since they fail to provide a comprehensive solution. To address this challenge, here we have hypothesized that a novel NIR-responsive phototherapeutic complex made with 3d-transition metal ions (preferably Zn<sup>2+</sup>), serum albumin (SA) and indocyanine green (ICG) will effectively work as a multifunctional therapeutic solution for the treatment of DFU. Under exposure to 808 nm Laser, ICG present in the Zn<sup>2+</sup>-SA-ICG complex will generate heat (photothermal effect) and ROS (photodynamic effect) which will kill the antibiotic-resistant bacteria in the wound milieu, Zn<sup>2+</sup> released from the complex will activate the endothelial cells and help in angiogenesis, and SA will serve as a sacrificial substrate to nullify the degrading effect of MMPs and will activate fibroblast and compensate the hypoalbuminemia. The hypothesis can be tested through a series of biophysical experiments, in vitro microbial and cellular studies, in vivo analysis in MRSA bacteria-infected wound models in STZ-induced diabetic mice and finally through clinical trials. If successful, a new domain of clinical management for DFU will be opened. This will also facilitate the pathway of similar innovation for even better therapy.</div></div>","PeriodicalId":18425,"journal":{"name":"Medical hypotheses","volume":"198 ","pages":"Article 111628"},"PeriodicalIF":2.1000,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical hypotheses","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0306987725000672","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Diabetic Foot Ulcer (DFU) is a severe chronic diabetes mellitus complication with delayed wound healing. A number of factors such as antibiotic-resistant bacterial infection, ischemia, matrix metalloproteinases (MMPs)- mediated degradation of granulating tissue, fibroblast senescence and hypoalbuminemia contribute to the severity of DFU. Present therapies are often found to be inactive since they fail to provide a comprehensive solution. To address this challenge, here we have hypothesized that a novel NIR-responsive phototherapeutic complex made with 3d-transition metal ions (preferably Zn2+), serum albumin (SA) and indocyanine green (ICG) will effectively work as a multifunctional therapeutic solution for the treatment of DFU. Under exposure to 808 nm Laser, ICG present in the Zn2+-SA-ICG complex will generate heat (photothermal effect) and ROS (photodynamic effect) which will kill the antibiotic-resistant bacteria in the wound milieu, Zn2+ released from the complex will activate the endothelial cells and help in angiogenesis, and SA will serve as a sacrificial substrate to nullify the degrading effect of MMPs and will activate fibroblast and compensate the hypoalbuminemia. The hypothesis can be tested through a series of biophysical experiments, in vitro microbial and cellular studies, in vivo analysis in MRSA bacteria-infected wound models in STZ-induced diabetic mice and finally through clinical trials. If successful, a new domain of clinical management for DFU will be opened. This will also facilitate the pathway of similar innovation for even better therapy.
期刊介绍:
Medical Hypotheses is a forum for ideas in medicine and related biomedical sciences. It will publish interesting and important theoretical papers that foster the diversity and debate upon which the scientific process thrives. The Aims and Scope of Medical Hypotheses are no different now from what was proposed by the founder of the journal, the late Dr David Horrobin. In his introduction to the first issue of the Journal, he asks ''what sorts of papers will be published in Medical Hypotheses? and goes on to answer ''Medical Hypotheses will publish papers which describe theories, ideas which have a great deal of observational support and some hypotheses where experimental support is yet fragmentary''. (Horrobin DF, 1975 Ideas in Biomedical Science: Reasons for the foundation of Medical Hypotheses. Medical Hypotheses Volume 1, Issue 1, January-February 1975, Pages 1-2.). Medical Hypotheses was therefore launched, and still exists today, to give novel, radical new ideas and speculations in medicine open-minded consideration, opening the field to radical hypotheses which would be rejected by most conventional journals. Papers in Medical Hypotheses take a standard scientific form in terms of style, structure and referencing. The journal therefore constitutes a bridge between cutting-edge theory and the mainstream of medical and scientific communication, which ideas must eventually enter if they are to be critiqued and tested against observations.